-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KQ/iiCV0zS5M+7mjfwBFSfdfw1dNlOkn2Ec5C+YTKxqaRYV5nUf9MeO/p/ptKQqj nhEp5YLJircWnQ70W8Yl2g== 0001181431-06-013809.txt : 20060223 0001181431-06-013809.hdr.sgml : 20060223 20060223151352 ACCESSION NUMBER: 0001181431-06-013809 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060221 FILED AS OF DATE: 20060223 DATE AS OF CHANGE: 20060223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Allaway Graham CENTRAL INDEX KEY: 0001329634 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24241 FILM NUMBER: 06639324 BUSINESS ADDRESS: BUSINESS PHONE: 240 631 1395 MAIL ADDRESS: STREET 1: C/O V.I. TECHNOLOGIES, INC. STREET 2: 209 PERRY PARKWAY CITY: GAITHERSBURG STATE: MD ZIP: 20877 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PANACOS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001040017 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 113238476 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 134 COOLIDGE AVE CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-926-1551 MAIL ADDRESS: STREET 1: 134 COOLIDGE AVE CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: V I TECHNOLOGIES INC DATE OF NAME CHANGE: 19980209 4 1 rrd108980.xml GRAHAM ALLAWAY FORM 4- FEB 21 2006 X0202 4 2006-02-21 0 0001040017 PANACOS PHARMACEUTICALS, INC. PANC 0001329634 Allaway Graham PANACOS PHARMACEUTICALS, INC. 209 PERRY PARKWAY GAITHERSBURG MD 20877 0 1 0 0 Chief Operating Officer Common stock 2006-02-21 4 M 0 5000 0.2251 A 56729 D Common stock 2006-02-21 4 M 0 2000 0.2251 A 58729 D Common stock 2006-02-21 4 S 0 5000 7.469 D 53729 D Common stock 2006-02-21 4 S 0 2000 7.8578 D 51729 D Stock option (right to buy) 0.2251 2006-02-21 4 M 0 7000 0.0 D 2005-03-11 2014-05-31 Common stock 7000 646514 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2005. Total grant of 660,584 stock options vests as follows: 378,448 stock options vested on March 11, 2005 and the remaining 282,136 stock options vest in equal increments on April 30, 2005, 2006, 2007 and 2008. /s/ Graham P. Allaway 2006-02-23 -----END PRIVACY-ENHANCED MESSAGE-----